APA (7th ed.) Citation

Shkhair, A. I., Madanan, A. S., Varghese, S., Abraham, M. K., Indongo, G., Rajeevan, G., . . . George, S. (2025). Erlotinib-Conjugated O-Phenylenediamine Derived Fluorescent Carbon Nanodots (OPD@CD) Platform for Targeting Breast Cancer (MCF-7) Cells. Journal of Fluorescence, 35(10), 9971. https://doi.org/10.1007/s10895-025-04279-x

Chicago Style (17th ed.) Citation

Shkhair, Ali Ibrahim, Anju S. Madanan, Susan Varghese, Merin K. Abraham, Geneva Indongo, Greeshma Rajeevan, Arathy B. K, Sara Muneer Abbas, and Sony George. "Erlotinib-Conjugated O-Phenylenediamine Derived Fluorescent Carbon Nanodots (OPD@CD) Platform for Targeting Breast Cancer (MCF-7) Cells." Journal of Fluorescence 35, no. 10 (2025): 9971. https://doi.org/10.1007/s10895-025-04279-x.

MLA (9th ed.) Citation

Shkhair, Ali Ibrahim, et al. "Erlotinib-Conjugated O-Phenylenediamine Derived Fluorescent Carbon Nanodots (OPD@CD) Platform for Targeting Breast Cancer (MCF-7) Cells." Journal of Fluorescence, vol. 35, no. 10, 2025, p. 9971, https://doi.org/10.1007/s10895-025-04279-x.